Previous 10 | Next 10 |
-- Record Second-Quarter 2021 Net Sales of $832.5 Million Increased 80 Percent; Second-Quarter 2021 GAAP Net Income of $158.1 Million; Adjusted EBITDA of $366.9 Million -- -- Record TEPEZZA® (teprotumumab-trbw) Second-Quarter 2021 Net Sales of $453.3 Million Driven by Str...
Sold out of the China uncertainty as I await a potential major flushing in those stocks if China decides to make an example out of a company like DiDi. A hit to Arrowhead Pharmaceuticals presented a buying opportunity while Bitcoin shows signs of wanting to break out. A portfolio ...
Shares of Horizon Therapeutics Public Limited Company (NASDAQ:HZNP) traded today at $104.85, eclipsing its 52-week high. Approximately 115,000 shares have changed hands today, as compared to an average 30-day volume of 1.6 million shares. Horizon Therapeutics PLC is a specialty and gener...
Galeanu Mihai/iStock via Getty Images Horizon Therapeutics ([[HZNP]] +3.7%) has climbed to a 52-week high after Cowen urged investors to “add right here” expecting the company to exceed expectations with its Q2 2021 earnings with a raise to annual outlook. The analyst Ken Caccia...
The CPI-W increased 6.1% year-over-year in June. Healthcare is historically a strong performer later in the business cycle. The healthcare sector is improving in our large cap sector ranking. Top scoring healthcare stocks worth adding to your watch list. For further deta...
Horizon Therapeutics plc (Nasdaq: HZNP) today announced that it has been named to the 2021 Fortune Best Workplaces for Millennials™ list for the second consecutive year. Horizon ranked 16th out of 100 large companies. “We are proud that Fortune has recognized our m...
janiecbros/E+ via Getty Images Biotech M&A is poised to heat up again as shares of the SPDR S&P Biotech’s (XBI) have fallen about 25% from their February highs, according to Jefferies. Biotech deals may pick up after a 3-6 month of a large "drawdown" and as prices "normalize" f...
Horizon Therapeutics plc (Nasdaq: HZNP) announced today that its second-quarter 2021 financial results will be released on Wednesday, Aug. 4, 2021. Following the announcement, Horizon's management will host a live webcast at 8 a.m. Eastern Time to review the Company's financial and oper...
Baker Brothers’ 13F portfolio value decreased from $26.54B to $23.07B this quarter. The large stake in Alexion Pharmaceuticals was decreased during the quarter. The top three positions are Seagen, BeiGene, and Incyte Corporation and they add up to almost ~57% of the portfol...
Massive trade on a binary event makes my month and helps eliminate much of my underperformance so far this year. Big buys on a couple of new stocks in June set my portfolio up for success as I consolidate my stocks down to more concentrated bets. A portfolio built for individual i...
News, Short Squeeze, Breakout and More Instantly...
Horizon Therapeutics Public Limited Company Company Name:
HZNP Stock Symbol:
NASDAQ Market:
Horizon Therapeutics Public Limited Company Website:
Hitachi Construction Machinery Co. Ltd ADR (HTCMY) is expected to report for Q2 2024 DigitalBridge Group Inc. (DBRG) is expected to report $0 for Q3 2023 LY Corp ADR (YAHOY) is expected to report for Q2 2024 DT Midstream Inc. (DTM) is expected to report $0.9 for Q3 2023 Summit Mat...
Horizon Therapeutics Public Limited Company (HZNP) is expected to report $1.22 for Q3 2023
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION FOR IMMEDIATE RELEASE October 6, 2023 RECOM...